Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge.

Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challenge.

Antisense oligonucleotide (AO)-mediated exon skipping is a promising new therapy for Duchenne muscular dystrophy (DMD), recently demonstrating proof of principle for restoring the absent dystrophin protein in DMD patients. However, the range of AO chemistries available for exon skipping is limited;...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Wood, M
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2010

Míreanna comhchosúla

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy.
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2011)

Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy.
de réir: Koo, T, et al.
Foilsithe / Cruthaithe: (2013)

PRO-051, an antisense oligonucleotide for the potential treatment of Duchenne muscular dystrophy.
de réir: Hammond, S, et al.
Foilsithe / Cruthaithe: (2010)

Progress in the Treatment of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
de réir: XU Tingting, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Casimersen (AMONDYS 45™): An Antisense Oligonucleotide for Duchenne Muscular Dystrophy
de réir: Milyard Assefa, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Cell penetrating peptide delivery of splice directing oligonucleotides as a treatment for Duchenne muscular dystrophy.
de réir: Betts, C, et al.
Foilsithe / Cruthaithe: (2013)

Challenges for antisense oligonucleotide-based therapeutics, in particular for exon 51-skipping in Duchenne muscular dystrophy
de réir: Aoki, Y, et al.
Foilsithe / Cruthaithe: (2011)

Progress in therapy for Duchenne muscular dystrophy.
de réir: Fairclough, R, et al.
Foilsithe / Cruthaithe: (2011)

Progress in therapy for Duchenne muscular dystrophy
de réir: Fairclough, R, et al.
Foilsithe / Cruthaithe: (2011)

Utrophin in the therapy of Duchenne Muscular Dystrophy
de réir: Potter, A, et al.
Foilsithe / Cruthaithe: (2006)

Duchenne Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1989-05-01)

New Approach for Antisense Oligonucleotide-Mediated Exon Skipping in Duchenne Muscular Dystrophy.
de réir: Aoki, Y, et al.
Foilsithe / Cruthaithe: (2012)

Therapeutic approaches for Duchenne muscular dystrophy
de réir: Roberts, TC, et al.
Foilsithe / Cruthaithe: (2023)

From diagnosis to therapy in Duchenne muscular dystrophy
de réir: Babbs, A, et al.
Foilsithe / Cruthaithe: (2020)

Early Development in Duchenne Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1990-07-01)

In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.
de réir: Wang, Q, et al.
Foilsithe / Cruthaithe: (2010)

Muscular Fatigue in Duchenne Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1995-02-01)

Glucocorticoids for Duchenne Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2013-07-01)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
de réir: Guiraud, S, et al.
Foilsithe / Cruthaithe: (2019)

Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches.
de réir: Fairclough, R, et al.
Foilsithe / Cruthaithe: (2013)

A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
de réir: Rachna Gulati, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Preclinical studies of WVE-210201, an investigational stereopure antisense oligonucleotide in development for the treatment of patients with duchenne muscular dystrophy (DMD)
de réir: Panzara, M, et al.
Foilsithe / Cruthaithe: (2017)

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
de réir: Perkins, K, et al.
Foilsithe / Cruthaithe: (2002)

Mechanisms of Chimeric Cell Therapy in Duchenne Muscular Dystrophy
de réir: Maria Siemionow, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Deletion analysis of Duchenne muscular dystrophy
de réir: H Erdem, et al.
Foilsithe / Cruthaithe: (1993-01-01)

Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model
de réir: Juri Hasegawa, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Molecular genetics of Duchenne muscular dystrophy.
de réir: Kunkel, L, et al.
Foilsithe / Cruthaithe: (1986)

Utrophin upregulation in Duchenne muscular dystrophy.
de réir: Hirst, R, et al.
Foilsithe / Cruthaithe: (2005)

Orthopaedic Management in Duchenne Muscular Dystrophy
de réir: Uma Balachandran, BA, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Delay in Diagnosis of Duchenne Muscular Dystrophy
de réir: Vamshi K Rao, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Prednisone-Treated Duchenne Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1991-06-01)

Language Delay in Duchenne’s Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2007-06-01)

Brain Function in Duchenne Muscular Dystrophy
de réir: J. Gordon Millichap
Foilsithe / Cruthaithe: (2002-02-01)

Epilepsy in Duchenne and Becker muscular dystrophies
de réir: Jesus Alfonso Armijo Gómez, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Cognition trajectory in Duchenne muscular dystrophy
de réir: Abeer A. Tony, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Imaging biomarkers for Duchenne muscular dystrophy
de réir: Koppaka, Sisir
Foilsithe / Cruthaithe: (2017)

Regenerative biomarkers for Duchenne muscular dystrophy
de réir: Guiraud, S, et al.
Foilsithe / Cruthaithe: (2019)

BREAKTHROUGH IN DUCHENNE MUSCULAR DYSTROPHY TREATMENT
de réir: article Editorial
Foilsithe / Cruthaithe: (2022-07-01)

NOVEL CELL PENETRATING PEPTIDES FOR SKELETAL AND CARDIAC MUSCLE DELIVERY OF PMO ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
de réir: Hammond, S, et al.
Foilsithe / Cruthaithe: (2011)

In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment
de réir: Marika Faiella, et al.
Foilsithe / Cruthaithe: (2024-08-01)